Targeted Strategies for Today's Evolving Markets

MissionIR Blog

ACADIA Pharmaceuticals, Inc. (ACAD) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

ACADIA Pharmaceuticals is a biopharmaceutical company with its focus on innovative treatments addressing unmet medical needs in neurological and related central nervous system disorders. Pimavanserin, which is in Phase III clinical development as a potential first-in-class treatment for Parkinson’s disease psychosis, leads the company’s pipeline of product candidates. All the company’s product candidates are small molecules emanating from discoveries made at ACADIA. For more information, visit the company’s Web site at http://www.acadia-pharm.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *